Development of Drugs and Therapies for Triple Negative Breast Cancer
The first thorough and current summary of contemporary techniques for diagnosing and treating triple-negative breast cancer
A group of eminent medical professionals presents an in-depth and authoritative review of current approaches to treating triple negative breast cancer (TNBC) in Drug and Therapy Development for Triple Negative Breast Cancer. The editors have included information on the disease’s molecular causes, preliminary detection, diagnostic equipment, therapeutic methods, pharmacology, and novel and experimental medicines, such as nanotherapeutics and photothermal therapies.
This reference is a one-of-a-kind repository of knowledge regarding present and potential treatment approaches, including machine learning techniques for early detection and more precise diagnosis. It is the first thorough compilation of contemporary treatment procedures for TNBC. Readers will also discover:
a comprehensive overview of HER receptors in breast cancer
thorough investigations of the causes, treatments, and early-stage diagnosis of hormone receptor-positive breast cancer
artificial intelligence used to diagnose breast cancer
new information on the stress on DNA replication and the instability of the genome in breast cancer
Drug and Therapy Development for Triple Negative Breast Cancer is ideal for medicinal and pharmaceutical chemists, as well as oncologists and specialists in the pharmaceutical or healthcare fields.
